Incyte to Present at Upcoming Investor Conference
News > Health News
Audio By Carbonatix
8:00 AM on Thursday, December 18
The Associated Press
WILMINGTON, Del.--(BUSINESS WIRE)--Dec 18, 2025--
Incyte (Nasdaq:INCY) announced today that it will present at the 44 th Annual J. P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 am (PST).
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte
A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.
For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.
View source version on businesswire.com:https://www.businesswire.com/news/home/20251218287907/en/
CONTACT: Incyte ContactsMedia
KEYWORD: DELAWARE UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH HEALTH PHARMACEUTICAL ONCOLOGY
SOURCE: Incyte
Copyright Business Wire 2025.
PUB: 12/18/2025 08:00 AM/DISC: 12/18/2025 08:03 AM
http://www.businesswire.com/news/home/20251218287907/en
